Tyrosine kinase inhibitors alone as a first-line treatment for patients with non-small-cell lung cancer harboring mutant epidermal growth factor receptor
2016 ◽
Vol 27
◽
pp. vi433
T. Iuchi
◽
M. Shingyoji
◽
M. Itakura
◽
Y. Hasegawa
◽
Y. Yoshida
◽
...
U. Rigney
◽
K. Lock
◽
C. Chen
◽
C. Escriu
2019 ◽
Vol 8
(6)
◽
pp. 1086-1090
Yusuke Chihara
◽
Tadaaki Yamada
◽
Junji Uchino
◽
Nobuyo Tamiya
◽
Yoshiko Kaneko
◽
...
K. Asami
◽
T. Koizumi
◽
K. Hirai
◽
S. Ameshima
◽
A. Tsukadaira
◽
...
2017 ◽
Vol 35
(6)
◽
pp. 692-692
◽
2011 ◽
Vol 9
(1)
◽
pp. 2
◽
G. de Lima Lopes
◽
J. Segel
◽
D. Tan
◽
Y. Do
◽
T. Mok
◽
...
2011 ◽
Vol 71
(3)
◽
pp. 249-257
◽
C. Gridelli
◽
F. De Marinis
◽
M. Di Maio
◽
D. Cortinovis
◽
F. Cappuzzo
◽
...
Fredrik O.L. Nilsson
◽
Peter Gal
◽
Ivan Houisse
◽
Jasmina I Ivanova
◽
Sandra T Asanin
Janette Greenhalgh
◽
Kerry Dwan
◽
Angela Boland
◽
Victoria Bates
◽
Fabio Vecchio
◽
...
2018 ◽
Vol 7
(S2)
◽
pp. S134-S137
◽
Lore Decoster
◽
Philippe Giron
◽
Sacha Mignon
◽
Jacques De Grève
2011 ◽
Vol 72
(1)
◽
pp. 3-8
◽
C. Gridelli
◽
F. De Marinis
◽
M. Di Maio
◽
D. Cortinovis
◽
F. Cappuzzo
◽
...
Close
Export Citation Format
Close
Share Document
Close